Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:42 PM UTC
| NCT Number | NCT07115329 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE2 |
| Target Enrollment | 164 participants |
| Active Locations | 32 sites in the US |
| Sponsor | Syndeio Biosciences, Inc |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of October 12, 2026: Clinical trial NCT07115329 is currently recruiting participants. This phase2 study for major depressive disorder is actively seeking new participants at 32 locations across the United States. The study is sponsored by Syndeio Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07115329 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07115329 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.